Why choose Mayo ClinicBy Mayo Clinic Staff
April 28, 2015
- Multidisciplinary team of specialized experts. Your Mayo Clinic team may include specialists in allergic diseases, dermatology, gastroenterology, pediatrics, neurology, endocrinology, hematology and pathology.
- Experience. Each year, doctors at Mayo Clinic treat more than 840 people with eosinophilia, including hypereosinophilic syndrome.
- Expertise. Mayo Clinic's mission is to research and share medical advancements and treatments. The Allergic Diseases Research Laboratory has been actively studying eosinophil biology for almost 50 years, aiming to understand the role of eosinophils in diseases such as hypereosinophilic syndrome. The Allergic Diseases Research Laboratory has had a National Institutes of Health grant in allergic diseases since the 1980s and provides training for doctors from many medical disciplines, with the goals of finding new treatments and eventually curing diseases such as hypereosinophilic syndrome.
- Care that revolves around you. At Mayo Clinic, a detailed itinerary for appointments, tests and procedures lets you make the most of your time at the clinic. Mayo Clinic technicians run all tests and labs themselves, which means tests taken in the morning can often be reviewed the same afternoon. Mayo's collaborative approach means two or three days often yields the same diagnosis and care insights that could take weeks in less-coordinated institutions.
- Hypereosinophilic syndrome (HES). American Academy of Allergy, Asthma and Immunology. http://www.aaaai.org/conditions-and-treatments/related-conditions/hypereosinophilic-syndrome.aspx. Accessed Jan. 29, 2015.
- AskMayoExpert. What is the definition of the hypereosinophilic syndrome? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
- Eosinophilia. The Merck Manual Professional Edition. http://www.merckmanuals.com/professional/hematology_and_oncology/eosinophilic_disorders/hyper eosinophilic_syndrome.html. Accessed Jan. 29, 2015.
- Roufosse F, et al. Clinical manifestations, pathophysiology, and diagnosis of the hypereosinophilic syndromes. http://www.uptodate.com/home. Jan. 29, 2015.
- Roufosse F, et al. Treatment of the hypereosinophilic syndromes. http://www.uptodate.com/home. Jan. 29, 2015.
- Gotlib J. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. American Journal of Hematology. 2014; 89:325-37.
- Golden AK. Decision Support System. Mayo Clinic, Rochester, Minn. Feb.12, 2015.
- Kita, H. Alternaria and ribonucleases in Th2-type immunity. National Institutes of Health. http://projectreporter.nih.gov/. Accessed March 17, 2015.